Elizabeth M. Swisher

Seattle Pacific University — United States

Medicine · Health Sciences

103h-index65.6kcitations732works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(309), Ovarian cancer diagnosis and treatment(242), BRCA gene mutations in cancer(176), Cancer Genomics and Diagnostics(136), DNA Repair Mechanisms(127)

Publications698 total

Cost-effectiveness of primary care-based risk assessment and hereditary cancer genetic testing
BMC Primary Care·2025Open Access
Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution
American Journal of Obstetrics and Gynecology·2025
ADAPTIVE MULTI-SCALE GRAPH TRANSFORMER FRAMEWORK FOR HISTOPATHOLOGICAL IMAGES
2025Open Access
Dynamic Monitoring of Recurrent Ovarian Cancer Using Serial ctDNA: A Real-World Case Series
Current Oncology·2025Open Access
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance
Nucleic Acids Research·2025Open Access
Diverse Patterns of Allele-Specific Expression in Healthy Human Tissues
2025Open Access
HRDPath: An Explainable Multi-Model Deep Learning Architecture for Predicting Homologous Recombination Deficiency from Histopathology Images
2025Open Access
Abstract A044: Application of HRDefine: a biomarker for identifying root causes of homologous recombination deficiency to a phase 3, randomized, placebo-controlled trial of veliparib in front-line treatment of advanced ovarian cancer (VELIA/GOG-3005)
Cancer Research·2025
Abstract PR016: Ultra-deep characterization of TP53 somatic evolution in the fallopian tube and its association with ovarian cancer risk
Cancer Research·2025
Abstract IA023: Clonal hematopoiesis and risk of therapy-related myeloid neoplasms in tubo-ovarian cancer survivors
Cancer Research·2025
Functional precision medicine profiling of patient-derived organoids identifies effective targeted therapies for patients with low-grade serous ovarian carcinoma
Gynecologic Oncology·2025
Early salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy: The first 2000 participants in the ongoing international TUBA-WISP II study
Gynecologic Oncology·2025
Homozygous loss of homologous repair genes and durable benefit from poly (ADP-ribose) polymerase inhibitors maintenance for patients with ovarian cancer
Gynecologic Oncology·2025
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
Cancer Cell·2025· 10 citedOpen Access
Comprehensive RAD51C ovarian cancer variant analysis uncouples homologous recombination and replicative functions
Nature Communications·2025· 3 citedOpen Access
Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity
Experimental Hematology and Oncology·2025Open Access
Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results
European Journal of Cancer·2025· 3 cited
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
European Journal of Cancer·2025· 4 citedOpen Access
Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study
American Journal of Obstetrics and Gynecology·2025Open Access
Folate receptor alpha (FRα; FOLR1) expression and persistence in ovarian cancer in clinical trial samples and real-world patient cohort.
Journal of Clinical Oncology·2025· 1 cited
page 1 of 35Next →

Frequent Co-authors

Maria I. Harrell(11), Robert L. Coleman(9), Clare L. Scott(8), Ming K. Lee(8), Mary‐Claire King(8), Amit M. Oza(7), Carol Aghajanian(7), Ana Oaknin(7), Iain A. McNeish(7), Scott H. Kaufmann(7), Tom Walsh(7), Alexandra Léary(6), David M. O’Malley(6), Lara Maloney(6), Heidi Giordano(6), Barbara M. Norquist(6), Silvia Casadei(6), Alan D. D’Andrea(6), Gottfried E. Konecny(5), James Sun(5)